CDKN2A and pancreatic ductal adenocarcinoma: ,23 High rates of CDKN2A HD have been identified in several neoplasms, including pleural mesothelioma, pancreatic ductal adenocarcinoma, malignant peripheral nerve sheath tumor, cutaneous melanoma, and colorectal carcinoma, among others.22